Update shared on 30 Oct 2025
Fair value Increased 4.10%Analysts have increased their price target for Great-West Lifeco from C$56.50 to C$58.82. They cite expectations for continued asset growth and platform expansion, which are anticipated to drive earnings upside and profitability improvements.
Analyst Commentary
Recent research notes highlight differing perspectives on Great-West Lifeco’s outlook, valuation, and growth trajectory. The company has drawn favorable rating initiations and price target increases associated with asset momentum and platform expansion initiatives.
Bullish Takeaways
- Bullish analysts see the potential for more than 8% upside to consensus 2026 earnings per share, citing robust growth in Retirement and Wealth assets under management.
- The company's strategic acquisitions of 401k platforms and continued efforts to transition retirees to its wealth platform are viewed as catalysts for incremental re-rating and valuation improvement.
- Ongoing asset growth and the expansion of operational platforms are expected to fuel earnings upside and bolster profitability over the medium term.
- Recent upward adjustments to price targets reflect optimism around execution on strategic initiatives and sustained growth in managed assets.
Bearish Takeaways
- Bearish analysts remain cautious about the pace and effective integration of acquired 401k platforms, which could present execution risk.
- There are concerns regarding the company's ability to consistently convert retirees to its wealth platform in a competitive industry environment.
- Some analysts note that elevated price targets depend on continued outperformance in asset growth, which may be susceptible to market volatility.
- Further upside to valuation depends on successful delivery of expanding profit margins, which could encounter challenges from rising operating costs or regulatory changes.
What's in the News
- Great-West Lifeco Inc. (TSX:GWO.PRT) and (TSX:GWO.PRZ) were added to the S&P/TSX Preferred Share Index (Key Developments).
- On September 3, 2025, the company announced an increase in its equity buyback plan by 20,000,000 shares, bringing total authorization to 40,000,000 shares (Key Developments).
- From April 1, 2025 to June 30, 2025, Great-West Lifeco repurchased 6,262,494 shares for CAD 321 million, completing the repurchase of 8,384,563 shares for CAD 432 million under its January 2025 buyback plan (Key Developments).
- During the second quarter 2025 conference call, the company reiterated openness to M&A, with a focus on workplace acquisitions in the U.S. and disciplined, technology-enabled growth strategies (Key Developments).
Valuation Changes
- The Fair Value Estimate has risen from CA$56.50 to CA$58.82, reflecting a moderate upward adjustment in analyst models.
- The Discount Rate remains unchanged at 5.97%, indicating a stable risk assessment by analysts.
- The Revenue Growth Projection is virtually flat and holds steady at approximately 5.83%.
- The Net Profit Margin has increased slightly from 10.11% to 10.47%, suggesting incremental improvements in profitability have been factored into forecasts.
- The estimated Future P/E Ratio has edged up from 14.95x to 15.02x, representing a minor increase in valuation expectations.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
